natgillin/translations-raw huggingface dataset:
The effectiveness of the product was further investigated in piglets which were directly exposed to the virus, by observing them for the development of circovirus-related symptoms.
Učinkovitost zdravila so nadalje preučevali pri pujskih, ki so bili neposredno izpostavljeni virusu, in sicer tako, da so opazovali pojav simptomov, povezanih s cirkovirusom.
The effectiveness of the product was measured by looking at the number of live parasites at various times after treatment.
Učinkovitost zdravila so merili s štetjem živih zajedavcev v različnih časovnih obdobjih po zdravljenju.
The effectiveness of the products against the specified parasites was investigated in laboratory studies.
Učinkovitost zdravila proti navedenim zajedavcem je bila raziskana v laboratorijskih študijah.
The effectiveness of the solution for injection was investigated in another study in cats undergoing orthopaedic surgery where animals were given Onsior solution for injection once before and once daily for up to 2 days after surgery.
Učinkovitost raztopine za injiciranje so proučevali v drugi študiji pri mačkah, ki so imele ortopedski operativni poseg, pri katerem so pred operativnim posegom prejele zdravilo Onsior v obliki raztopine za injiciranje in nato enkrat dnevno največ dva dni po posegu.
The effectiveness of the tablets was measured based on the need to provide extra analgesic treatment (pain relief) to cats following surgery.
Učinkovitost tablet so merili na podlagi potrebe po dodatnem protibolečinskem zdravljenju (lajšanju bolečin) pri mačkah po operativnem posegu.
The effectiveness of the vaccine was compared with that of a placebo (dummy) vaccine in two laboratory studies involving 232 fattening rabbits intended for meat production.
Učinkovitost cepiva so primerjali z učinkovitostjo placeba (cepiva brez zdravilne učinkovine) v dveh laboratorijskih študijah, ki sta vključevali 232 pitanih kuncev za prirejo mesa.
The effectiveness of the vaccine was first studied in a number of laboratory studies in pigs.
Učinkovitost cepiva so najprej raziskali v več laboratorijskih študijah na prašičih.
The effectiveness of Truvada in reducing the risk of acquiring HIV-1 is strongly correlated with adherence as demonstrated by measurable drug levels in blood.
Učinkovitost zdravila Truvada za zmanjšanje tveganja za okužbo s HIV–1 je v veliki meri odvisno od adherence, kar prikazujejo merljive koncentracije učinkovin v krvi.
The effectiveness of Vectra 3D against fleas, ticks, mosquitoes and flies was investigated in 24 laboratory studies and in two field studies.
Učinkovitost zdravila Vectra 3D proti bolham, klopom, komarjem in muham so preučevali v 24 laboratorijskih študijah in dveh študijah na terenu.
The effectiveness of Vectra Felis against fleas was investigated in a large number of laboratory studies and in one field study.
Učinkovitost zdravila Vectra Felis proti bolham so raziskali v zelo številnih laboratorijskih študijah in eni terenski študiji.
The effectiveness of Zycortal was investigated in a field study involving 152 dogs with Addison’s disease.
Učinkovitost zdravila Zycortal so raziskovali v terenski študiji, v katero je bilo vključenih 152 psov z Addisonovo boleznijo.
The effectiveness was determined based on both examinations by a veterinarian and assessments by the animal’s owner of some signs of osteoarthritis (such as lameness, pain or difficulty moving).
Učinkovitost je bila ugotovljena na podlagi pregledov veterinarjev in ocen lastnikov živali glede določenih znakov osteoartritisa (na primer šepavost, bolečine ali težave pri gibanju).
The effectiveness was determined based on examinations by a veterinarian and assessments by the animal’s owner.
Učinkovitost je bila določena na podlagi veterinarjevega pregleda živali in ocene lastnika živali.
The effectiveness was determined by the level of iron in the liver before and after one year of treatment with the medicines.
Učinkovitost so merili z opazovanjem ravni železa v jetrih pred enoletnim zdravljenjem z zdravili in po njem.
The effectiveness was measured by counting the number of fleas and ticks at fortnightly intervals.
Učinkovitost so merili s štetjem bolh in klopov v štirinajstdnevnih razmikih.
The effectiveness was measured by looking at the number of treatment failures (rejection or loss of the new kidney, or death) after six months.
Merilo učinkovitosti je bilo število neuspelih zdravljenj (zavrnitve ali izgube presajene ledvice ali smrti) po šestih mesecih.
The effectiveness was measured by looking at the number of worm eggs or parts of tapeworms passed out in the animal’s faeces after treatment.
Učinkovitost je bila merjena z ugotavljanjem števila jajčec ali delov trakulje, izločenih z blatom po zdravljenju.
The effectiveness was measured using a score card to record symptoms (feeling feverish, muscle pain, headache, sore throat, cough, overall discomfort and runny nose).
Učinkovitost so merili s točkovalno kartico za beleženje simptomov (vročina, bolečine v mišicah, glavobol, boleče žrelo, kašelj, splošno slabo počutje in izcedek iz nosu).
The effects are expected to last for the patient’s lifetime.
Pričakovano je, da učinki trajajo vse življenje.
The effects include:
Ti učinki vključujejo:
The effects of Adcetris were first tested in experimental models before being studied in humans.
Učinki zdravila Adcetris so bili najprej preskušeni na poskusnih modelih, nato pa so jih raziskali pri ljudeh.
The effects of adding NovoMix 30 to other antidiabetes medicines taken by mouth (metformin, sulphonylureas and pioglitazone) have also been studied in four studies involving a total of 905 patients.
Učinke dodajanja zdravila NovoMix 30 k drugim zdravilom za zdravljenje sladkorne bolezni, ki se jemljejo peroralno (metforminu, sulfonilsečnini in pioglitazonu), so proučevali v štirih študijah, v katerih je sodelovalo skupno 905 bolnikov.
The effects of adding Remicade to existing treatment have also been studied in 103 children and adolescents with Crohn’s disease who were aged between six and 17 years.
Učinke dodajanja zdravila Remicade obstoječemu zdravljenju so proučevali tudi pri 103 otrocih in mladostnikih s Crohnovo boleznijo, starih od šest do 17 let.
The effects of Afinitor were studied in four main studies.
Učinke zdravila Afinitor so proučevali v štirih glavnih študijah.
The effects of age on the pharmacokinetics of fluticasone furoate and vilanterol were determined in phase III studies in COPD and asthma.
Vplive starosti na farmakokinetiko flutikazonfuroata in vilanterola so preučili v študijah III. faze pri KOPB in astmi.
The effects of aliskiren on warfarin pharmacokinetics have not been evaluated.
Učinkov aliskirena na farmakokinetične lastnosti varfarina niso ocenjevali.
The effects of an overdose of Luveris are unknown, nevertheless there is a possibility that Ovarian Hyper-Stimulation Syndrome may occur, which is further described in ‘Possible side effects'.
Učinki prevelikega odmerka zdravila Luveris niso poznani, vseeno pa je možen pojav sindroma ovarijske hiperstimulacije, kar je podrobno opisano v „Možni neželeni učinki“.
The effects of an overdose of Pergoveris are unknown, nevertheless one could expect OHSS to occur.
Učinki prevelikega odmerka zdravila Pergoveris niso znani, vendar pa lahko pričakujemo pojav OHSS.
The effects of Bretaris Genuair were first tested in experimental models before being studied in humans.
Učinki zdravila Bretaris Genuair so bili najprej preizkušeni na poskusnih modelih, nato pa so jih raziskali pri ljudeh.
The effects of Caprelsa were first tested in experimental models before being studied in humans.
Učinki zdravila Caprelsa so bili najprej preskušeni na poskusnih modelih, nato pa so jih raziskali pri ljudeh.
The effects of Celsentri, taken once or twice a day, were compared with those of placebo (a dummy treatment).
Učinke zdravila Celsentri, prejetega enkrat ali dvakrat na dan, so primerjali z učinki placeba (zdravila brez zdravilne učinkovine).
The effects of Deltyba have been looked at in one main study involving 481 adults with tuberculosis resistant to standard treatments.
Učinke zdravila Deltyba so preučevali v eni glavni študiji, ki je vključila 481 odraslih bolnikov s tuberkulozo, odporno proti standardnim oblikam zdravljenja.
The effects of desloratadine in poor metabolizers < 2 years of age have not been studied.
Učinkov zdravila desloratadin pri bolnikih, mlajših od 2 let, ki slabo presnavljajo zdravilo, niso raziskovali.
The effects of Dexdor were first tested in experimental models before being studied in humans.
Učinki zdravila Dexdor so bili najprej preskušeni na poskusnih modelih, nato pa so jih raziskali pri ljudeh.
The effects of Eklira Genuair were first tested in experimental models before being studied in humans.
Učinki zdravila Eklira Genuair so bili najprej preizkušeni na poskusnih modelih, nato pa so jih raziskali pri ljudeh.
The effects of Enurev Breezhaler were first tested in experimental models before being studied in humans.
Učinki zdravila Enurev Breezhaler so bili najprej preskušeni na poskusnih modelih, nato pa so jih raziskali pri ljudeh.
The effects of Enviage on warfarin pharmacokinetics have not been evaluated.
Učinkov zdravila Enviage na farmakokinetične lastnosti varfarina niso ocenjevali.
The effects of Fampyra were first tested in experimental models before being studied in humans.
Učinki zdravila Fampyra so bili najprej preskušeni na poskusnih modelih, nato pa so jih raziskali pri ljudeh.
The effects of Faslodex on fertility in humans has not been studied.
Vpliv zdravila Faslodex na plodnost pri človeku ni raziskan.
The effects of food on bioavailability are not considered clinically relevant to the use of anagrelide.
Učinki hrane na biološko uporabnost niso klinično relevantni za uporabo anagrelida.
The effects of Forxiga were first tested in experimental models before being studied in humans.
Učinki zdravila Forxiga so bili najprej preskušeni na poskusnih modelih, nato pa so jih raziskali pri ljudeh.
The effects of gender on the pharmacokinetics of Viramune prolonged-release have been investigated in study 1100.1486. Female patients tend to have higher (approximately 20 – 30 %) trough concentrations in both Viramune prolonged-release and Viramune immediate-release treatment groups.
Vpliv spola na farmakokinetiko zdravila Viramune s podaljšanim sproščanjem so proučevali v študiji 1100.1486. Pri ženskah so opazili nekoliko večje (približno za 20 do 30 %) koncentracije pred naslednjim odmerkom v skupini, ki je jemala zdravilo Viramune s podaljšanim sproščanjem, in skupini, ki je jemala zdravilo Viramune s takojšnjim sproščanjem.
The effects of gender on the pharmacokinetics of Viramune prolonged-release have been investigated in study 1100.1486. Female patients tend to have higher (approximately 20 – 30%) trough concentrations in both Viramune prolonged-release and Viramune immediate-release treatment groups.
Vpliv spola na farmakokinetiko zdravila Viramune s podaljšanim sproščanjem so proučevali v študiji 1100.1486. Pri ženskah so opazili nekoliko večje (približno za 20 do 30 %) koncentracije pred naslednjim odmerkom v skupini, ki je jemala zdravilo Viramune s podaljšanim sproščanjem, in skupini, ki je jemala zdravilo Viramune s takojšnjim sproščanjem.
The effects of giving one, two or three doses of Bexsero (at intervals of at least one month) were compared with giving placebo (a dummy treatment).
Učinke dajanja enega, dveh ali treh odmerkov cepiva Bexsero (v razmiku vsaj enega meseca) so primerjali z dajanjem placeba (zdravila brez zdravilne učinkovine).
The effects of giving three doses of Bexsero at two-month intervals together with other routine infant vaccinations were compared with giving the routine vaccinations alone.
Učinke dajanja treh odmerkov cepiva Bexsero v razmiku dveh mesecev in skupaj z drugimi rutinskimi cepljenji dojenčkov so primerjali z dajanjem samih rutinskih cepiv.
The effects of hepatic impairment on thiotepa metabolism and elimination have not been assessed.
Vpliv na presnovo in odstranjevanje tiotepe pri motnjah v delovanju jeter ni bil ocenjen.
The effects of high
flutikazon propionat: 
The effects of Humira in pregnant women are not known and so the use of Humira in pregnant women is not recommended.
Vplivi zdravila Humira pri nosečnicah niso znani, zato uporaba tega zdravila pri nosečih ženskah ni priporočljiva.
The effects of INCRELEX on unborn child have not been studied.
Vplivov zdravila INCRELEX na nerojenega otroka niso raziskovali.
The effects of InductOs on pregnancy are not known.
Vpliv zdravila InductOs na nosečnost ni znan.
The effects of Infanrix hexa were compared with those of separate vaccines containing the same active substances.
Učinke cepiva Infanrix hexa so primerjali z učinki ločenih cepiv, ki so vsebovala iste zdravilne učinkovine.
The effects of inhaled nitric oxide are rapid, decrease in pulmonary artery pressure and improved oxygenation is seen within 5-20 minutes.
Učinki inhaliranega dušikovega oksida so hitri, saj se znižanje tlaka v pljučni arteriji in izboljšanje oksigenacije pojavita v 5–20 minutah.
The effects of intravenous zoledronic acid in the treatment of paediatric patients (age 1 to 17 years) with severe osteogenesis imperfecta (types I, III and IV) were compared to intravenous pamidronate in one international, multicentre, randomised, open-label study with 74 and 76 patients in each treatment group, respectively.
Učinke intravenske zoledronske kisline pri pediatričnih bolnikih s hudo osteogenesis imperfecta tipov I, III in IV (starih od 1 do 17 let), so primerjali z intravenskim pamidronatom v eni mednarodni, multicentrični, randomizirani, odprti študiji s 74 oziroma 76 bolniki v vsaki od zdravljenih skupin.
The effects of intravenous zoledronic acid in the treatment of paediatric patients (aged 1 to 17 years) with severe osteogenesis imperfecta (types I, III and IV) were compared to intravenous pamidronate in one international, multicentre, randomised, open-label study with 74 and 76 patients in each treatment group, respectively.
Delovanje intravenske zoledronske kisline pri zdravljenju pediatričnih bolnikov (starih od 1 leta do 17 let) s hudo obliko osteogenesis imperfecta (tipov I, III in IV) so primerjali z intravenskim pamidronatom v eni mednarodni, multicentrični, randomizirani, odprti študiji s 74 oziroma 76 bolniki v vsaki od zdravljenih skupin.
The effects of irbesartan both on renal and cardiovascular events were not uniform across all subgroups, in an analysis carried out in the study with patients with advanced renal disease.
Analiza rezultatov raziskave, v kateri so spremljali bolnike z napredovalo ledvično boleznijo, je pokazala, da učinki irbesartana na ledvične in srčno-žilne dogodke znotraj podskupin niso enaki.
The effects of irbesartan both on renal and cardiovascular events were not uniform across all subgroups, in an analysis carried out in the study with patients with advanced renal disease.
Analiza rezultatov študije z bolniki z napredovalo ledvično boleznijo kaže, da učinki irbesartana tako na ledvične kot srčnožilne dogodke niso enotni znotraj podskupin.
The effects of Jevtana were compared with another cancer medicine, mitoxantrone.
Učinke zdravila Jevtana so primerjali z učinki drugega zdravila proti raku, mitoksantrona.
The effects of Jevtana were first tested in experimental models before being studied in humans.
Učinki zdravila Jevtana so bili najprej preskušeni na poskusnih modelih, nato pa so jih raziskali pri ljudeh.
The effects of Kaletra (in combination with other antiretroviral agents) on biological markers (plasma HIV RNA levels and CD4+ T-cell counts) have been investigated in controlled studies of Kaletra of 48 to 360 weeks duration.
Učinke zdravila Kaletra (v kombinaciji z drugimi protiretrovirusnimi zdravili) na biološke označevalce (koncentracijo HIV RNA in število celic CD4 v plazmi) so raziskali v kontrolirani 48- tedenski študiji zdravila Kaletra ter v dodatnih 360-tedenskih raziskavah zdravila Kaletra.
The effects of Kaletra (in combination with other antiretroviral agents) on biological markers (plasma HIV RNA levels and CD4+ T-cell counts) have been investigated in controlled studies of Kaletra of 48 to 360 weeks duration.
Učinke zdravila Kaletra (v kombinaciji z drugimi protiretrovirusnimi zdravili) na biološke označevalce (koncentracijo HIV RNA in število celic CD4 v plazmi) so raziskali v kontrolirani 48- tedenski študiji zdravila Kaletra ter v dodatnih 360-tedenskih študijah zdravila Kaletra.
The effects of long-term treatment of Prialt are uncertain at this time and the possibility of toxic effects on the spinal cord have not yet been ruled out.
Učinki dolgoročne uporabe zdravila Prialt so zaenkrat nejasni in možnosti toksičnih učinkov na podaljšano hrbtenjačo še niso izključili.
The effects of lopinavir/ritonavir (in combination with other antiretroviral agents) on biological markers (plasma HIV RNA levels and CD4+ T-cell counts) have been investigated in controlled studies of lopinavir/ritonavir of 48 to 360 weeks duration.
Učinke lopinavirja/ritonavirja (v kombinaciji z drugimi protiretrovirusnimi zdravili) na biološke označevalce (koncentracijo HIV RNA in število celic CD4 v plazmi) so raziskali v kontrolirani 48- tedenski študiji lopinavirja/ritonavirja ter v dodatnih 360-tedenskih študijah lopinavirja/ritonavirja.
The effects of lyophilised AVONEX in the treatment of MS were demonstrated in a placebo- controlled study of 301 patients (AVONEX n=158, placebo n=143) with relapsing MS characterised by at least 2 exacerbations in the previous 3 years or at least one exacerbation per year prior to entry when the duration of the disease was less than 3 years.
Učinki liofiliziranega zdravila AVONEX pri zdravljenju MS so bili prikazani v s placebom kontrolirani študiji, opravljeni na 301 bolniku (zdravilo AVONEX n=158, placebo n=143) s ponavljajočo se multiplo sklerozo, ki so v preteklih treh letih doživeli vsaj dva povratna napada nevrološke disfunkcije (relapsa) ali vsaj enim zagonom na leto pred vstopom v študijo, če je čas trajanja bolezni krajši od treh let.
The effects of medicinal products with similar properties such as the inotropes milrinone, enoximone, amrinone, olprinone and cilostazol may be exacerbated by anagrelide.
Anagrelid utegne poslabšati učinke zdravil s podobnimi lastnostmi, kot so inotropna zdravila milrinon, enoksimon, amrinon, olprinon in cilostazol.
The effects of medicines such as ciclosporin, mycophenolate mofetil and tacrolimus (medicines used in transplant patients) may be reduced by Renagel.
Učinke zdravil kot so ciklosporin, mofetilmikofenolat in takrolimus (zdravila, ki zavirajo odziv imunskega sistema), lahko zdravilo Renagel zmanjša.
The effects of medicines such as ciclosporin, mycophenolate mofetil and tacrolimus (medicines used in transplant patients) may be reduced by Tasermity.
Učinke zdravil kot so ciklosporin, mofetilmikofenolat in takrolimus (zdravila, ki zavirajo odziv imunskega sistema), lahko zdravilo Tasermity zmanjša.
The effects of medicines such as ciclosporin, mycophenolate mofetil and tacrolimus (medicines used to suppress the immune system) may be reduced by Renvela.
Učinke zdravil kot so ciklosporin, mikofenolat mofetil in takrolimus (zdravila, ki zavirajo odziv imunskega sistema), lahko zdravilo Renvela zmanjša.
The effects of medicines such as ciclosporin, mycophenolate mofetil and tacrolimus (medicines used to suppress the immune system) may be reduced by Renvela.
Učinke zdravil kot so ciklosporin, mofetilmikofenolat in takrolimus (zdravila, ki zavirajo odziv imunskega sistema), lahko zdravilo Renvela zmanjša.
The effects of medicines such as ciclosporin, mycophenolate mofetil and tacrolimus (medicines used to suppress the immune system) may be reduced by Sevelamer carbonate Zentiva.
Učinke zdravil kot so ciklosporin, mikofenolat mofetil in takrolimus (zdravila, ki zavirajo odziv imunskega sistema), lahko zdravilo Sevelamer carbonate Zentiva zmanjša.
The effects of medicines such as ciclosporin, mycophenolate mofetil and tacrolimus (medicines used to suppress the immune system) may be reduced by Sevelamer carbonate Zentiva.
Učinke zdravil kot so ciklosporin, mofetilmikofenolat in takrolimus (zdravila, ki zavirajo odziv imunskega sistema), lahko zdravilo Sevelamer carbonate Zentiva zmanjša.
The effects of nalmefene on the ability to drive and use machines have not been studied.
Raziskave o vplivih nalmefena na sposobnost vožnje in upravljanje s stroji niso bile izvedene.
The effects of naltrexone / bupropion on weight loss, weight maintenance, waist circumference, body composition, obesity-related markers for cardiovascular and metabolic parameters and patient reported assessments were examined in double-blind, placebo-controlled obesity Phase 2 and Phase 3 trials (BMI range 27-45 kg/m2) with study durations of 16 to 56 weeks randomised to naltrexone hydrochloride (16 to 50 mg/day) and/or bupropion hydrochloride (300 to 400 mg/day) or placebo.
Učinki kombinacije naltrekson/bupropion na zmanjšanje oziroma ohranjanje telesne mase, obseg pasu, sestavo telesa, označevalce v zvezi z debelostjo za kardiovaskularne in presnovne parametre ter ocene po navedbi bolnikov so bili raziskani v dvojno slepih, s placebom nadzorovanih preskušanjih 2. in 3. faze glede debelosti (razpon ITM: 27–45 kg/m2), študije pa so trajale od 16 do 56 tednov in so bile randomizirane za uporabo naltreksonijevega klorida (16 do 50 mg/dan) in/ali bupropionijevega klorida (300 do 400 mg/dan) ali placeba.
The effects of once- and twice-daily doses of Celsentri were similar.
Odmerki zdravila Celsentri, enkrat oziroma dvakrat dnevno so bili podobno učinkoviti.
The effects of OPDIVO in pregnant women are not known, but it is possible that the active substance, nivolumab, could harm an unborn baby.
Učinki zdravila OPDIVO pri nosečnicah niso znani, vendar pa obstaja možnost, da zdravilna učinkovina nivolumab škoduje nerojenemu otroku.
The effects of Orgalutran on ability to drive and use machines have not been studied.
Študije o vplivu zdravila Orgalutran na sposobnost vožnje in upravljanja s stroji niso bile izvedene.
The effects of overdose on egg formation and the egg laying process have not been established in chickens.
Učinki prevelikega odmerjanja na nastanek jajc in postopek valjenja pri piščancih niso bili ugotovljeni.
The effects of P-gp and BCRP inducers and inhibitors on vemurafenib exposure are unknown.
Vplivi induktorjev in inhibitorjev P-gp in BCRP na izpostavljenost vemurafenibu niso znani.
The effects of Perjeta were compared with placebo (a dummy treatment) when given together with other cancer medicines (trastuzumab and docetaxel).
Učinke zdravila Perjeta v kombinaciji z drugimi zdravili za zdravljenje raka (trastuzumabom in docetakselom) so primerjali s placebom (zdravilom brez zdravilne učinkovine).
The effects of Plenadren were investigated in one main study involving 64 patients with adrenal insufficiency.
Učinke zdravila Plenadren so raziskali v eni glavni študiji, ki je vključevala 64 bolnikov z adrenalno insuficienco.
The effects of plerixafor on male and female fertility are not known (see section 5.3).
Učinki pleriksaforja na plodnost pri moških in ženskah niso znani (glejte poglavje 5.3).
The effects of race and sex on plasma eltrombopag CL/F estimates were consistent between pediatric and adult patients.
Vpliv rase in spola na ocenjen navidezni očistek eltrombopaga iz plazme je pri pediatričnih bolnikih podoben kot pri odraslih bolnikih.
The effects of Rasilamlo on all cause and cardiovascular mortality and on cardiovascular morbidity and target organ damage are currently unknown.
Zaenkrat ni znano, kako zdravilo Rasilamlo vpliva na umrljivost iz kateregakoli vzroka, na kardiovaskularno umrljivost, na kardiovaskularno obolevnost in morebitno škodljivo delovanje na tarčne organe.
The effects of Rasilez on warfarin pharmacokinetics have not been evaluated.
Učinkov zdravila Rasilez na farmakokinetične lastnosti varfarina niso ocenjevali.
The effects of renal impairment on thiotepa elimination have not been assessed.
Vpliv na odstranjevanje tiotepe pri motnjah v delovanju ledvic ni bil ocenjen.